We are a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
$14.00 - $16.00
May 9, 2019
JEFFERIES LLC, COWEN AND COMPANY, LLC, PIPER JAFFRAY & CO., OPPENHEIMER & CO. INC.
To view the prospectus for Milestone Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253